CoChat

Rapid and safe response to low‐dose carbamazepine in neonatal epilepsy

Sands, Tristan T., Balestri, Martina, Bellini, Giulia, Mulkey, Sarah B., Danhaive, Olivier, Bakken, Eliza Hayes, Taglialatela, Maurizio, Oldham, Michael S., Vigevano, Federico, Holmes, Gregory L., Cilio, Maria Roberta · 2016 · Epilepsia
Cited by 135

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Summary: Objective: To evaluate treatment responses in benign familial neonatal epilepsy (BFNE). Methods: We recruited patients with BFNE through a multicenter international collaboration and reviewed electroclinical and genetic details, and treatment response. All patients were tested at minimum for mutations/deletions in the KCNQ 2, KCNQ 3, and SCN 2A genes. Results: Nineteen patients were included in this study. A family history of neonatal seizures was positive in 16 patients, and one additional patient had a family history of infantile seizures. Mutations or deletions of KCNQ 2 were found in 14, and of KCNQ 3 in 2, of the 19 patients. In all patients, seizures began at 2–5 days of life and occurred multiple times per day. Four patients developed status epilepticus. Seizures were focal, alternating between hemispheres, and characterized by asymmetric tonic posturing associated with apnea and desaturation, followed by unilateral or bilateral asynchronous clonic jerking. Twelve of 19 patients were treated with multiple medications prior to seizure cessation. Seventeen of (88%) 19 patients were seizure‐free within hours of receiving oral carbamazepine (CBZ) or oxcarbazepine (OXC). Earlier initiation of CBZ was associated with shorter hospitalization (p < 0.01). No side effects of CBZ were reported. All patients had normal development and remain seizure‐free at a mean follow‐up period of 7.8 years (6 months–16 years). Significance: This study provides evidence that CBZ is safe and rapidly effective in neonates with BFNE, even in status epilepticus. We propose that CBZ should be the drug of choice in benign familial neonatal seizures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/epi.13596

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 135

Metadata

Authors
Sands, T. T., Balestri, M., Bellini, G., Mulkey, S. B., Danhaive, O., Bakken, E. H., Taglialatela, M., Oldham, M. S., Vigevano, F., Holmes, G. L., & Cilio, M. R.
Venue
Epilepsia
Publisher
Wiley
Published
2016-11-26
Volume
57
Issue
12
Pages
2019-2030
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2549867175
Cited by
135
References
2
FWCI
7.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapid and safe response to low‐dose carbamazepine in neonatal epilepsy. https://app.cochat.ai/papers/10.1111/epi.13596
The paper
Sands, T. T., Balestri, M., Bellini, G., Mulkey, S. B., Danhaive, O., Bakken, E. H., Taglialatela, M., Oldham, M. S., Vigevano, F., Holmes, G. L., & Cilio, M. R. (2016). Rapid and safe response to low‐dose carbamazepine in neonatal epilepsy. Epilepsia. https://doi.org/10.1111/epi.13596

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.